Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2015-10-26
Original market date: See footnote 1
1994-12-31
Product name:
RATIO-CLONAZEPAM
DIN:
02103737 Electronic product monograph is not available
Company:
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada
M1B 2K9
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Targeted (CDSA IV)
American Hospital Formulary Service (AHFS): See footnote 3
28:12.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
N03AE01 CLONAZEPAM
Active ingredient group (AIG) number:See footnote5
0111558002
Active ingredient(s) See footnote8 | Strength |
---|---|
CLONAZEPAM | 2 MG |